Discontinued — last reported Q1 '19
Products & Services · Research And Development Expense
Elenbecestat Collaboration — Research And Development Expense
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2019
Rolls up toR&D
How to read this metric
An increase suggests intensified clinical development or regulatory activity, while a decrease may indicate project completion, prioritization shifts, or cost-sharing adjustments with the partner.
Detailed definition
This metric represents the specific research and development costs allocated to the collaborative development of elenbec...
Peer comparison
Similar to R&D spending on specific partnered pipeline assets at other large-cap biopharmaceutical companies, where costs are often shared or milestone-driven.
Metric ID:
biib_segment_elenbecestat_collaboration_research_and_development_expenseSimilar Metrics at Other Companies
Frequently Asked Questions
- What does elenbecestat collaboration — research and development expense mean?
- The amount of money spent on research and development activities for the elenbecestat drug partnership.